Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies

ClinicalTrials.gov ID: NCT01307319

Public ClinicalTrials.gov record NCT01307319. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 6:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Study of Two Doses of an Investigational Nasal Aerosol Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the safety and efficacy of an investigational nasal aerosol at two doses compared with placebo nasal aerosol in the treatment of seasonal allergic rhinitis in children (6-11 years of age).

Study identification

NCT ID
NCT01307319
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
715 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Years to 11 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2011
Primary completion
Jun 30, 2011
Completion
Jul 31, 2011
Last update posted
Feb 19, 2015

2011

United States locations

U.S. sites
45
U.S. states
17
U.S. cities
43
Facility City State ZIP Site status
Teva Clinical Study Site Oxford Alabama 36203
Teva Clinical Study Site Bell California 90201
Teva Clinical Study Site Costa Mesa California 92626
Teva Clinical Study Site Mission Viejo California 92691
Teva Clinical Study Site Orange California 92868
Teva Clinical Study Site Paramount California 90723
Teva Clinical Study Site San Diego California 92120
Teva Clinical Study Site San Diego California 92123
Teva Clinical Study Site Stockton California 95207
Teva Clinical Study Site Centennial Colorado 80112
Teva Clinical Study Site Colorado Springs Colorado 80907
Teva Clinical Study Site Gainesville Georgia 30501
Teva Clinical Study Site Lawrenceville Georgia 30046
Teva Clinical Study Site Savannah Georgia 31406
Teva Clinical Study Site Stockbridge Georgia 30281
Teva Clinical Study Site Indianapolis Indiana 43208
Teva Clinical Study Site Bethesda Maryland 20814
Teva Clinical Study Site Minneapolis Minnesota 55402
Teva Clinical Study Site Plymouth Minnesota 55441
Teva Clinical Study Site Columbia Missouri 65203
Teva Clinical Study Site Rolla Missouri 65401
Teva Clinical Study Site Warrensburg Missouri 64093
Teva Clinical Study Site Bozeman Montana 597158
Teva Clinical Study Site Brick New Jersey 08724
Teva Clinical Study Site High Point North Carolina 27262
Teva Clinical Study Site Oklahoma City Oklahoma 73102
Teva Clinical Study Site Portland Oregon 97213
Teva Clinical Study Site Blue Bell Pennsylvania 19422
Teva Clinical Study Site Collegeville Pennsylvania 19426
Teva Clinical Study Site Philadelphia Pennsylvania 19115
Teva Clinical Study Site Pittsburgh Pennsylvania 15241
Teva Clinical Study Site Charleston South Carolina 20460
Teva Clinical Study Site Orangeburg South Carolina 29119
Teva Clinical Study Site Austin Texas 78731
Teva Clinical Study Site Dallas Texas 75230
Teva Clinical Study Site Dallas Texas 75246
Teva Clinical Study Site El Paso Texas 79903
Teva Clinical Study Site Fort Worth Texas 76132
Teva Clinical Study Site Houston Texas 77054
Teva Clinical Study Site Kerrville Texas 78028
Teva Clinical Study Site New Braunfels Texas 78130
Teva Clinical Study Site San Antonio Texas 78229
Teva Clinical Study Site Waco Texas 76712
Teva Clinical Study Site Burke Virginia 22015
Teva Clinical Study Site Richmond Virginia 23233

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01307319, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 19, 2015 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01307319 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →